Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Falconi

Showing results (481-490 of 557) with videos related to

Pageof 56
Sort By:
Cancers|May 20, 2020
A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort StudyFlorian Primavesi, Valentina Andreasi, Frederik J H Hoogwater, et al.
The Journal of Urology|July 22, 2014
Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinomaMatteo Santoni, Alessandro Conti, Camillo Porta, et al.
Endocrine Connections|September 2, 2016
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease managementKjell Oberg, Eric Krenning, Anders Sundin, et al.
Annals of Surgical Oncology|March 10, 2024
The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine TumorsStefano Partelli, Francesca Fermi, Giuseppe K Fusai, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
Consensus on molecular imaging and theranostics in neuroendocrine neoplasmsValentina Ambrosini, Jolanta Kunikowska, Eric Baudin, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 5, 2025
Clinical features and evolution of paraduodenal (groove) pancreatitis: A multicenter studyGiacomo Emanuele Maria Rizzo, Matteo Tacelli, Stefano Francesco Crinò, et al.
Endocrine Pathology|May 13, 2022
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 CasesAlessandro Vanoli, Oneda Grami, Catherine Klersy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 28, 2026
Real life management of intraductal papillary mucinous neoplasms of the pancreas: Final data from the prospective Italian pancreatic cysts (PANCY) registryStefano Crippa, Germana de Nucci, Giulio Belfiori, et al.
Surgery|May 1, 2021
The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysisFabio Casciani, Maxwell T Trudeau, Horacio J Asbun, et al.
Journal of Neuroendocrinology|November 26, 2024
Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire studyCarolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, et al.
Pageof 56

Showing results (481-490 of 557) with videos related to

Sort By:
Pageof 56
Cancers|May 20, 2020
A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort StudyFlorian Primavesi, Valentina Andreasi, Frederik J H Hoogwater, et al.
The Journal of Urology|July 22, 2014
Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinomaMatteo Santoni, Alessandro Conti, Camillo Porta, et al.
Endocrine Connections|September 2, 2016
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease managementKjell Oberg, Eric Krenning, Anders Sundin, et al.
Annals of Surgical Oncology|March 10, 2024
The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine TumorsStefano Partelli, Francesca Fermi, Giuseppe K Fusai, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
Consensus on molecular imaging and theranostics in neuroendocrine neoplasmsValentina Ambrosini, Jolanta Kunikowska, Eric Baudin, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 5, 2025
Clinical features and evolution of paraduodenal (groove) pancreatitis: A multicenter studyGiacomo Emanuele Maria Rizzo, Matteo Tacelli, Stefano Francesco Crinò, et al.
Endocrine Pathology|May 13, 2022
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 CasesAlessandro Vanoli, Oneda Grami, Catherine Klersy, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 28, 2026
Real life management of intraductal papillary mucinous neoplasms of the pancreas: Final data from the prospective Italian pancreatic cysts (PANCY) registryStefano Crippa, Germana de Nucci, Giulio Belfiori, et al.
Surgery|May 1, 2021
The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysisFabio Casciani, Maxwell T Trudeau, Horacio J Asbun, et al.
Journal of Neuroendocrinology|November 26, 2024
Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire studyCarolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, et al.
Pageof 56